Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects

被引:71
作者
Yang, Xiao-Hong
Man, Xiao-Yong
Cai, Sul-Qing
Yao, Yong-Gang
Bu, Zhang-Yu
Zheng, Min [1 ]
机构
[1] Zhejiang Univ, Sch Med, Dept Dermatol, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China
[2] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
VEGF; VEGFR-2; HaCaT cell; keratinocyte; phosphorylation; PLC-gamma; p44/42; MAPK; cell proliferation; cell migration; cell adhesion;
D O I
10.1016/j.bbrc.2006.07.213
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 play important roles in mitogenesis and chemotaxis of endothelial cells. In normal human skin, VEGF is expressed and secreted by epidermal keratinocytes. Emerging data suggest that keratinocyte-derived VEGF targets other cell types besides the dermal endothelial cells. We have recently showed that keratinocytes from human normal skin expressed all five known VEGF receptors and co-receptors (neuropilin 1 and 2). To define the functional significance of VEGFR-2 in epidermis, we examined its role in a keratinocyte cell line, HaCaT cells, in response to VEGF treatment. Expression of VEGFR-2 on HaCaT cells was confirmed at both RNA and protein levels and was regulated by VEGF(165) treatment. Treatment of HaCaT cells with VEGF(165) induced tyrosine-autophosphorylation of VEGFR-2 and phosphorylation of PLC-gamma and p44/42 MAPK in a time-dependent manner. Preincubation with a neutralizing antibody for VEGFR-2 (MAB3571) completely abrogated these phosphorylation effects. Furthermore, VEGF(165) Stimulated proliferation and migration of HaCaT cells, and this effect was significantly blocked by a pretreatment with MAB3571. Neutralizing VEGFR-2 in HaCaT cells increased cell adhesion during culture. Our results suggest that VEGFR-2 expressed on HaCaT cells plays a crucial role in VEGF-mediated regulation of cell activity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 46 条
[1]
Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism [J].
Ancelin, M ;
Chollet-Martin, S ;
Hervé, MA ;
Legrand, C ;
El Benna, J ;
Perrot-Applanat, M .
LABORATORY INVESTIGATION, 2004, 84 (04) :502-512
[2]
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[3]
EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING [J].
BROWN, LF ;
YEO, KT ;
BERSE, B ;
YEO, TK ;
SENGER, DR ;
DVORAK, HF ;
VANDEWATER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1375-1379
[4]
Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[5]
Signal transduction by vascular endothelial growth factor receptors [J].
Claesson-Welsh, L .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 :20-24
[6]
ACTIVATION OF MAP KINASE KINASE IS NECESSARY AND SUFFICIENT FOR PC12 DIFFERENTIATION AND FOR TRANSFORMATION OF NIH 3T3 CELLS [J].
COWLEY, S ;
PATERSON, H ;
KEMP, P ;
MARSHALL, CJ .
CELL, 1994, 77 (06) :841-852
[7]
OVEREXPRESSION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS IN PSORIASIS [J].
DETMAR, M ;
BROWN, LF ;
CLAFFEY, KP ;
YEE, KT ;
KOCHER, O ;
JACKMAN, RW ;
BERSE, B ;
DVORAK, HF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1141-1146
[8]
Hypoxia regulates the expression of vascular permeability factor vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin [J].
Detmar, M ;
Brown, LF ;
Berse, B ;
Jackman, RW ;
Elicker, BM ;
Dvorak, HF ;
Claffey, KP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (03) :263-268
[9]
Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications [J].
Ferrara, N .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :10-14
[10]
The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676